Analysis of Pleurotin binding to human thioredoxin reductase using docking and molecular dynamics simulation

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Thioredoxin reductase (TrxR) is crucial for cellular redox homeostasis and a potential target for cancer chemotherapy.
• Interfering with TrxR function can induce apoptosis, a key tumor suppression mechanism.
• Despite extensive research, no TrxR inhibitors have been approved for human therapy.

Purpose of the Study:

• To identify novel natural organic compounds as potential TrxR inhibitors through virtual screening.
• To investigate the binding mechanism and allosteric effects of identified inhibitors.
• To provide quantitative insights into ligand-receptor interactions using molecular dynamics.

Main Methods:

• Virtual screening of 72 natural organic compounds with known IC-50 values for TrxR inhibition.
• Molecular docking to predict binding modes and interactions within the TrxR active site.
• Long molecular dynamics simulations to analyze binding energies and conformational changes.

Main Results:

• Pleurotin, a naphthoquinone from Hohenbuehelia grisea, was identified as a promising TrxR inhibitor.
• Pleurotin binds to the TrxR active site, hindering essential conformational changes required for enzyme function.
• Simultaneous docking revealed allosteric correlation between the two binding sites, where one ligand can impede the binding of another.

Conclusions:

• Pleurotin represents a potential lead compound for developing new cancer therapeutics targeting TrxR.
• Understanding the allosteric interactions of TrxR inhibitors is crucial for drug design.
• Molecular dynamics simulations offer a comprehensive approach to characterizing ligand-enzyme interactions.